Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVS-beta vs methylprednisolone acetate for symptomatic knee osteoarthritis
2004-005261-38Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of hylan gf-20 in knee osteoarthritis (OA), sponsored by Sanofi. Started Jun 2005; status: completed.
02
Drugs
hylan gf-20
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2004-005261-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005261-38.